Neurocrine Biosciences Increase (Decrease) in Inventories decreased by 226.5% to -$4.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 352.9%, from $1.70M to -$4.30M.
An increase may signal expected demand growth or supply chain bottlenecks, while a decrease might indicate strong sales or inventory optimization efforts.
Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This...
Standard metric for manufacturing and industrial firms; essential for evaluating inventory turnover and operational health.
other_increase_decrease_in_inventories| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.80M | $5.00M | -$1.50M | $7.70M | -$1.80M | -$1.60M | -$2.90M | -$1.10M | $5.30M | $3.30M | $11.60M | $1.70M | -$2.10M | $12.30M | $3.40M | -$4.30M |
| QoQ Change | — | +278.6% | -130.0% | +613.3% | -123.4% | +11.1% | -81.3% | +62.1% | +581.8% | -37.7% | +251.5% | -85.3% | -223.5% | +685.7% | -72.4% | -226.5% |
| YoY Change | — | — | — | +375.0% | -20.0% | — | -137.7% | +38.9% | +431.3% | +213.8% | — | +254.5% | -139.6% | +272.7% | -70.7% | -352.9% |